Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Oncternal Therapeutics Inc (ONCT)
NASDAQ:ONCT
RESEARCH TOOLSreports
Holding ONCT?
Track your performance easily
Oncternal Therapeutics (ONCT) Ownership Overview
42.14% Insiders
5.88% Mutual Funds
0.45% Other Institutional Investors
4.73% ETFs
46.79% Public Companies and
Individual Investors
The ownership structure of Oncternal Therapeutics (ONCT) stock is a mix of institutional, retail, and individual investors. Approximately 11.06% of the company’s stock is owned by Institutional Investors, 42.14% is owned by Insiders, and 46.79% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Apr 10, 2024 | Robert James Wills Director | xxxxxxxxxxxxx | $27651 |
| Apr 01, 2024 | Robert James Wills Director | xxxxxxxxxxxxx | $58562 |
| Feb 27, 2024 | Robert James Wills Director | xxxxxxxxxxxxx | $8859 |
| Feb 27, 2024 | David F. Hale Director | xxxxxxxxxxxxx | $8859 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 655,737 | Insider | 22.16% | 1,062,294 | |
| 147,282 | Insider | 4.98% | 238,597 | |
| 139,050 | Institution | 4.70% | 225,261 | |
| 139,050 | Institution | 4.70% | 225,261 | |
| 128,635 | Insider | 4.35% | 208,389 | |
| 84,758 | Insider | 2.86% | 137,308 | |
| 71,947 | Insider | 2.43% | 116,554 | |
| 44,019 | Insider | 1.49% | 71,311 | |
| 31,304 | Insider | 1.06% | 50,712 | |
| 26,174 | Insider | 0.88% | 42,402 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 139,050 | Institution | 4.70% | 225,261 | |
| 23,824 | Institution | 0.80% | 38,595 | |
| 5,861 | Institution | 0.20% | 9,495 | |
| 1,701 | Institution | 0.06% | 2,756 | |
| 1,612 | Institution | 0.05% | 2,611 | |
| 1,458 | Institution | 0.05% | 2,362 | |
| 406 | Institution | 0.01% | 658 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 107,989 | Institution | 3.65% | 142,545 | |
| 31,061 | Institution | 1.05% | 41,001 | |
| 1,002 | Institution | 0.03% | 1,503 |
FAQ
Who Owns Oncternal Therapeutics Inc (ONCT)?
According to the latest TipRanks data, approximately 0.45% of the company's stock is held by institutional investors, 42.14% is held by insiders, and 46.79% is held by retail investors.
What percentage of Oncternal Therapeutics Inc (ONCT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.45% of Oncternal Therapeutics Inc (ONCT) stock is held by institutional investors.
What percentage of Oncternal Therapeutics Inc (ONCT) stock is held by retail investors?
According to the latest TipRanks data, approximately 46.79% of Oncternal Therapeutics Inc (ONCT) stock is held by retail investors.
Who owns the most shares of Oncternal Therapeutics Inc (ONCT)?
James Breitmeyer owns the most shares of Oncternal Therapeutics Inc (ONCT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.